Endocrine methods of ovulation induction

被引:7
作者
Balen, A [1 ]
机构
[1] Gen Infirm, Dept Obstet & Gynaecol, Leeds LS2 9NS, W Yorkshire, England
来源
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY | 1998年 / 12卷 / 04期
关键词
anovulation; polycystic ovary syndrome; hyperinsulinaemia; clomiphene citrate; metformin; gonadotrophin therapy; follicle-stimulating hormone;
D O I
10.1016/S0950-3552(98)80049-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The rationale of ovulation induction is to achieve the development of a single follicle and ultimately a singleton healthy baby. Problems faced by women with anovulatory polycystic ovary syndrome are the sensitivity of the ovary to stimulation and health issues such as obesity. This chapter will discuss medical management including strategies to lose weight, address hyperinsulinaemia with insulin-sensitizing agents, such as metformin, and outline methods of ovulation induction from the usual first-line therapy of clomiphene citrate and the subsequent use of gonadotrophin therapy in clomiphene-resistant patients. Appropriately directed surgical ovulation induction with laparoscopic ovarian diathermy appears to be as efficacious as gonadotrophin therapy but will not be discussed in the context of this chapter.
引用
收藏
页码:521 / 539
页数:19
相关论文
共 123 条
[31]   Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Schneider, DJ ;
Sobel, BE ;
Cavaghan, MK ;
Imperial, J ;
Rosenfield, RL ;
Polonsky, KS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (07) :2108-2116
[32]  
EHRMANN DA, 1997, J CLIN ENDOCRINOLOGY, V82, P1241
[33]   TRIGGERING OVULATION WITH ENDOGENOUS LUTEINIZING-HORMONE MAY PREVENT THE OVARIAN HYPERSTIMULATION SYNDROME [J].
EMPERAIRE, JC ;
RUFFIE, A .
HUMAN REPRODUCTION, 1991, 6 (04) :506-510
[34]  
ESHEL A, 1988, FERTIL STERIL, V49, P956
[35]  
*ESHRE, 1997, ESHRE CAPR WORKSH HU, V12, P1191
[36]   Early prediction of ovarian multifollicular response during ovulation induction in patients with polycystic ovary syndrome [J].
Farhi, J ;
Jacobs, HS .
FERTILITY AND STERILITY, 1997, 67 (03) :459-462
[37]   THE CHOICE OF TREATMENT FOR ANOVULATION ASSOCIATED WITH POLYCYSTIC-OVARY-SYNDROME FOLLOWING FAILURE TO CONCEIVE WITH CLOMIPHENE [J].
FARHI, J ;
HOMBURG, R ;
LERNER, A ;
BENRAFAEL, Z .
HUMAN REPRODUCTION, 1993, 8 (09) :1367-1371
[38]  
FAUSER BCJM, 1994, GYNECOL ENDOCRINOL, V8, P75
[39]   THE STEP-DOWN PRINCIPLE IN GONADOTROPIN TREATMENT AND THE ROLE OF GNRH ANALOGS [J].
FAUSER, BCJM ;
DONDERWINKEL, P ;
SCHOOT, DC .
BAILLIERES CLINICAL OBSTETRICS AND GYNAECOLOGY, 1993, 7 (02) :309-330
[40]   TREATMENT OF ANOVULATION WITH PULSATILE GONADOTROPIN-RELEASING-HORMONE - PROGNOSTIC FACTORS AND CLINICAL-RESULTS IN 600 CYCLES [J].
FILICORI, M ;
FLAMIGNI, C ;
DELLAI, P ;
COGNIGNI, G ;
MICHELACCI, L ;
ARNONE, R ;
SAMBATARO, M ;
FALBO, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04) :1215-1220